Etoricoxib in the treatment of rheumatoid arthritis: A 12-week, placebo-controlled and active-comparator, double-blind US study

被引：0
|
作者：
Melian, A
Curtis, S
Matsumoto, A
Zhao, PL
McCormick, CL
Rodgers, DB
Gertz, BJ
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2001年 / 44卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
LB7
引用
收藏
页码：2947 / 2947
页数：1
相关论文
共 50 条
  • [1] Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: A randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial
    Leung, AT
    Malmstrom, K
    Gallacher, AE
    Sarembock, B
    Poor, G
    Beaulieu, A
    Castro, R
    Sanchez, M
    DeTora, LM
    Ng, J
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (02) : 49 - 58
  • [2] Lumiracoxib (Prexige™) is effective in the treatment of osteoarthritis of the knee:: A 13-week, placebo-controlled, active-comparator, double-blind study.
    Tannenbaum, H
    Berenbaum, F
    Reginster, JY
    Zacher, J
    Robinson, J
    Poor, G
    Bliddal, H
    Uebelhart, D
    Adami, S
    Navarro, F
    Lee, A
    Moore, A
    Gimona, A
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S212 - S212
  • [3] Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double-Blind, Active Comparator- and Placebo-Controlled Study
    Blanco, Francisco J.
    Moericke, Ruediger
    Dokoupilova, Eva
    Codding, Christine
    Neal, Jeffrey
    Andersson, Mats
    Rohrer, Susanne
    Richards, Hanno
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 (06) : 1144 - 1153
  • [4] A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: A 12-week, double-blind, randomized, placebo-controlled study
    Lan, JL
    Chou, SJ
    Chen, DY
    Chen, YH
    Hsieh, TY
    Young, M
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2004, 103 (08) : 618 - 623
  • [5] QUINAPRIL IN HEART INSUFFICIENCY - A DOUBLE-BLIND PLACEBO-CONTROLLED 12-WEEK MULTICENTER STUDY
    RIEGGER, AJG
    [J]. ZEITSCHRIFT FUR KARDIOLOGIE, 1987, 76 : 103 - 103
  • [6] Efficacy and Safety of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis Receiving Background Methotrexate Therapy: A 12-week, Double-blind, Randomized Placebo-controlled Study
    Tanaka, Yoshiya
    Emoto, Kahaku
    Cai, Zhihong
    Aoki, Takehiro
    Schlichting, Douglas
    Rooney, Terence
    Macias, William
    [J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (03) : 504 - 511
  • [7] Efficacy and Safety of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis Receiving Background Methotrexate Therapy: A 12-Week, Double-Blind, Randomized Placebo-Controlled Study
    Lunzer, R.
    [J]. JOURNAL FUR MINERALSTOFFWECHSEL & MUSKULOSKELETTALE ERKRANKUNGEN, 2016, 23 (02): : 60 - 60
  • [8] Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled study
    Ogrendik, Mesut
    [J]. RHEUMATOLOGY INTERNATIONAL, 2006, 26 (12) : 1132 - 1137
  • [9] Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled study
    Mesut Ogrendik
    [J]. Rheumatology International, 2006, 26 : 1132 - 1137
  • [10] Risperidone for severe tardive dyskinesia: A 12-week randomized, double-blind, placebo-controlled study
    Bai, YM
    Yu, SC
    Lin, CC
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (11) : 1342 - 1348
12345